Regulating the therapeutic translation of regenerative medicine
Maude L Cuchiara1, Jackie K Olive1, Kirstin Matthews1
1a Rice University, Baker Institute for Public Policy , 6100 Main Street, MS-40, Houston, TX 77005, USA krwm@rice.edu.
Abstract:
Regenerative medicine and stem cell research are exciting new fields. But as the fields progress toward clinical therapies, controversies emerge. Hype surrounding stem cell research has caused an increase in their use in interventions that are not clinically proven. Furthermore, the regulatory agencies have a lot of difficulty dealing with cell therapies, which are distinctly different from drugs and medical devices they more commonly approve. To move the field forward, advocates, regulators and scientists need to come together to find new options for stem cell research oversight that protects both the patients and the research field.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Gene Therapy
Gene Therapy
Forced Transdifferentiation
Artificial...
iPS Cell Differentiation


